Canadian integrative oncology research priorities: results of a consensus-building process

  • L.C. Weeks Ottawa Integrative Cancer Centre
  • D. Seely Ottawa Integrative Cancer Centre, Canadian College of Naturopathic Medicine, Ottawa Hospital Research Institute
  • L.G. Balneaves University of British Columbia
  • H.S. Boon University of Toronto
  • A. Leis University of Saskatoon
  • D. Oneschuk University of Alberta
  • S.M. Sagar McMaster University, Juravinski Cancer Centre
  • M.J. Verhoef University of Calgary
Keywords: Integrative oncology, research priorities, consensus development, Canada, complementary medicine, CAM

Abstract

Background

In Canada, many diverse models of integrative oncology care have emerged in response to the growing number of cancer patients who combine complementary therapies with their conventional medical treatments. The increasing interest in integrative oncology emphasizes the need to engage stakeholders and to work toward consensus on research priorities and a collaborative research agenda. The Integrative Canadian Oncology Research Initiative initiated a consensus-building process to meet that need and to develop an action plan that will implement a Canadian research agenda.

Methods

A two-day consensus workshop was held after completion of a Delphi survey and stakeholder interviews.

Results

Five interrelated priority research areas were identified as the foundation for a Canadian research agenda:

• Effectiveness
• Safety
• Resource and health services utilization
• Knowledge translation
• Developing integrative oncology models

Research is needed within each priority area from a range of different perspectives (for example, patient, practitioner, health system) and in a way that reflects a continuum of integration from the addition of a single complementary intervention within conventional cancer care to systemic change. Strategies to implement a Canadian integrative oncology research agenda were identified, and working groups are actively developing projects in line with those strategic areas. Of note is the intention to develop anational network for integrative oncology research and knowledge translation.

Conclusions

The identified research priorities reflect the needs and perspectives of a spectrum of integrative oncology stakeholders. Ongoing stakeholder consultation, including engagement from new stakeholders, is needed to ensure appropriate uptake and implementation of a Canadian research agenda.

Author Biographies

L.C. Weeks, Ottawa Integrative Cancer Centre
Researcher
D. Seely, Ottawa Integrative Cancer Centre, Canadian College of Naturopathic Medicine, Ottawa Hospital Research Institute
Founder and Executive Director, Director
L.G. Balneaves, University of British Columbia
Associate Professor, School of Nursing
H.S. Boon, University of Toronto
Professor, Leslie Dan Faculty of Pharmacy
A. Leis, University of Saskatoon
Department of Community Health and Epidemiology
D. Oneschuk, University of Alberta
Division of Palliative Medicine, Department of Oncology, Palliative Medicine Physician
S.M. Sagar, McMaster University, Juravinski Cancer Centre
Department of Oncology
M.J. Verhoef, University of Calgary
Professor, Department of Community Health Sciences
How to Cite
Weeks, L., Seely, D., Balneaves, L., Boon, H., Leis, A., Oneschuk, D., Sagar, S., & Verhoef, M. (1). Canadian integrative oncology research priorities: results of a consensus-building process. Current Oncology, 20(4), e289-e299. https://doi.org/10.3747/co.20.1378
Section
Integrative Oncology